Secondary Navigation Menu

Audience Switcher Modal

Country and Audience Choose Modal

Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.

Scientific Congress Publications

Supported by Bayer Pharmaceuticals

ESOC 2025

Incidence of ischaemic stroke recurrence in patients after non-cardioembolic ischaemic stroke in Denmark: observation from ASTRIS ​
Date/Time:
Wednesday, May 21, 2025 / 9:20 – 9:30 AM, EET​
Presenting Author:
David Gaist​
Abstract Number:
215​
Download the presentation
Rate of vascular events after the first hospitalisation for non-cardioembolic ischaemic stroke or transient ischaemic attack in real-world settings in Japan: observations from ASTRIS
Date/Time:
Wednesday, May 21, 2025 / 10:00 – 10:30 AM, EET​
Presenting Author:
Terry Hirano​
Poster Number: ​
406​
Download the presentation
Incidence of ischaemic stroke recurrence in patients after non-cardioembolic ischaemic stroke in England: observation from ASTRIS
Date/Time:
Thursday, May 22, 2025 / 10:00 – 10:30 AM, EET
Presenting Author:
Deborah Lowe​
Poster Number: ​
989​
Download the poster
Back to Stroke Prevention

© 2025 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.

Copies of the Bayer Pharmaceuticals supported presentations obtained from this platform are for personal use only and may not be reproduced or distributed without permission from the authors.

Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities, and the presentations are shared in the interest of scientific exchange.

For any questions, please contact Medical Information at https://www.medicalinformation.bayer.com/

PP-GEN-ALL-0014-1